Anti-BTLA Agonist Therapy in Subjects With Primary Sjogren's Syndrome

Clinical trial NCT05781451 · WITHDRAWN

Trial details

NCT number: NCT05781451
Sponsor: Stanford University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sjogren's Syndrome

Start date: 2025-01-01
Primary completion: 2027-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.